The most expensive drug in the U.S. is now Lenmeldy, a $4.25 million gene therapy the FDA approved March 18 for children with a rare genetic disease.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
The most expensive drug in the U.S. is now Lenmeldy, a $4.25 million gene therapy the FDA approved March 18 for children with a rare genetic disease.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis